| Lifesource Of North Carolina | |
|
200 Nursing Home Ln Pikeville KY 41501-6896 | |
| (910) 742-9243 | |
| (888) 746-1787 |
| Full Name | Lifesource Of North Carolina |
|---|---|
| Speciality | Social Worker |
| Location | 200 Nursing Home Ln, Pikeville, Kentucky |
| Authorized Official Name and Position | Peggy Baddour (PRESIDENT) |
| Authorized Official Contact | 9107779165 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Lifesource Of North Carolina Po Box 538622 Atlanta GA 30353-8622 Ph: (910) 535-1211 | Lifesource Of North Carolina 200 Nursing Home Ln Pikeville KY 41501-6896 Ph: (910) 742-9243 |
| NPI Number | 1538728183 |
|---|---|
| Provider Enumeration Date | 06/07/2019 |
| Last Update Date | 03/25/2021 |
| Certification Date | 03/25/2021 |
| Medicare PECOS PAC ID | 7416132428 |
|---|---|
| Medicare Enrollment ID | O20190620002144 |
News Archive
International researchers centered at Nagoya University use a highly sensitive technique to identify significantly more DNA sequence repeats in patients with schizophrenia than in control individuals, and outline a possible link between genome instability and disease.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
Pharmacyclics, Inc. today announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research 2010 Annual Meeting being held April 17-21 in Washington, DC.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538728183 | NPI | - | NPPES |
| Provider Name | Steven Shelton |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1215934310 PECOS PAC ID: 6406754910 Enrollment ID: I20050510000331 |
News Archive
International researchers centered at Nagoya University use a highly sensitive technique to identify significantly more DNA sequence repeats in patients with schizophrenia than in control individuals, and outline a possible link between genome instability and disease.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
Pharmacyclics, Inc. today announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research 2010 Annual Meeting being held April 17-21 in Washington, DC.
› Verified 5 days ago
| Provider Name | Sarah E Parsons |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1124041686 PECOS PAC ID: 9739286923 Enrollment ID: I20090723000048 |
News Archive
International researchers centered at Nagoya University use a highly sensitive technique to identify significantly more DNA sequence repeats in patients with schizophrenia than in control individuals, and outline a possible link between genome instability and disease.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
Pharmacyclics, Inc. today announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research 2010 Annual Meeting being held April 17-21 in Washington, DC.
› Verified 5 days ago
| Provider Name | Charlene Cochran |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1881960953 PECOS PAC ID: 6406017300 Enrollment ID: I20120420000316 |
News Archive
International researchers centered at Nagoya University use a highly sensitive technique to identify significantly more DNA sequence repeats in patients with schizophrenia than in control individuals, and outline a possible link between genome instability and disease.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
Pharmacyclics, Inc. today announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research 2010 Annual Meeting being held April 17-21 in Washington, DC.
› Verified 5 days ago
| Provider Name | Natashia Little |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1760858799 PECOS PAC ID: 9436467834 Enrollment ID: I20151005002824 |
News Archive
International researchers centered at Nagoya University use a highly sensitive technique to identify significantly more DNA sequence repeats in patients with schizophrenia than in control individuals, and outline a possible link between genome instability and disease.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
Pharmacyclics, Inc. today announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research 2010 Annual Meeting being held April 17-21 in Washington, DC.
› Verified 5 days ago
| Provider Name | Willie James Campbell |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1417217092 PECOS PAC ID: 1456500545 Enrollment ID: I20190626003879 |
News Archive
International researchers centered at Nagoya University use a highly sensitive technique to identify significantly more DNA sequence repeats in patients with schizophrenia than in control individuals, and outline a possible link between genome instability and disease.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
Pharmacyclics, Inc. today announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research 2010 Annual Meeting being held April 17-21 in Washington, DC.
› Verified 5 days ago
| Provider Name | Crystal Coleman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1427522028 PECOS PAC ID: 2668709569 Enrollment ID: I20190815001920 |
News Archive
International researchers centered at Nagoya University use a highly sensitive technique to identify significantly more DNA sequence repeats in patients with schizophrenia than in control individuals, and outline a possible link between genome instability and disease.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
Pharmacyclics, Inc. today announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research 2010 Annual Meeting being held April 17-21 in Washington, DC.
› Verified 5 days ago
| Provider Name | Kelley Fulkerson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1578942140 PECOS PAC ID: 4385070036 Enrollment ID: I20200129000447 |
News Archive
International researchers centered at Nagoya University use a highly sensitive technique to identify significantly more DNA sequence repeats in patients with schizophrenia than in control individuals, and outline a possible link between genome instability and disease.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
Pharmacyclics, Inc. today announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research 2010 Annual Meeting being held April 17-21 in Washington, DC.
› Verified 5 days ago
| Provider Name | Angela S Ellison |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1871134999 PECOS PAC ID: 0446684856 Enrollment ID: I20200619001980 |
News Archive
International researchers centered at Nagoya University use a highly sensitive technique to identify significantly more DNA sequence repeats in patients with schizophrenia than in control individuals, and outline a possible link between genome instability and disease.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
Pharmacyclics, Inc. today announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research 2010 Annual Meeting being held April 17-21 in Washington, DC.
› Verified 5 days ago
| Provider Name | Harold Kweku Bedu-addo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922620624 PECOS PAC ID: 6709282924 Enrollment ID: I20210913002743 |
News Archive
International researchers centered at Nagoya University use a highly sensitive technique to identify significantly more DNA sequence repeats in patients with schizophrenia than in control individuals, and outline a possible link between genome instability and disease.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
Pharmacyclics, Inc. today announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research 2010 Annual Meeting being held April 17-21 in Washington, DC.
› Verified 5 days ago
News Archive
International researchers centered at Nagoya University use a highly sensitive technique to identify significantly more DNA sequence repeats in patients with schizophrenia than in control individuals, and outline a possible link between genome instability and disease.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Copper deficiency diseases can be devastating. Symptoms can range from crippling neurological degeneration in Menkes disease ,a classic copper deficiency disease to brittle bones, anaemia and defective skin pigmentation in gastric bypass patients. Unfortunately, very little is known about how the body uses this essential nutrient. Knowing that melanocytes (the cells that give rise to hair, skin and eye pigmentation) are dramatically affected by the effects of copper deficiency, Elizabeth Patton from the University of Edinburgh, UK, and other colleagues from UK and US based labs decided to find out how melanocytes metabolise copper.
Pharmacyclics, Inc. today announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research 2010 Annual Meeting being held April 17-21 in Washington, DC.
› Verified 5 days ago
Pikeville Neurology Clinic & Diagnostic Center Psc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 515 N Bypass Rd, Suite 101, Pikeville, KY 41501 Phone: 606-437-4100 Fax: 606-432-6009 | |
Psychiatric Center Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1330 S Mayo Trl, Nova Complex Suite 301, Pikeville, KY 41501 Phone: 606-432-7233 Fax: 606-432-7255 | |
Meta Medical Center Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 8857 Meta Hwy, Meta Medical Center, Pikeville, KY 41501 Phone: 606-631-1222 Fax: 606-631-1226 | |
Asap Plus Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 122 Division St, Suite 202, Pikeville, KY 41501 Phone: 606-437-0097 | |
Carter And May, Qmhp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 178 2nd St Ste B, Pikeville, KY 41501 Phone: 606-432-1287 Fax: 606-509-2345 | |
Fazal And Associates Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 255 Church St Ste 100, Pikeville, KY 41501 Phone: 606-791-6115 | |
Commonwealth Psychological Services Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 147 Main St, Suite 210, Pikeville, KY 41501 Phone: 859-338-8024 Fax: 606-432-3890 |